Free Trial

Affirm (AFRM) Stock Forecast & Price Target

$41.16
-0.48 (-1.15%)
(As of 09/27/2024 08:50 PM ET)

Affirm - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
5
Hold
9
Buy
7

Based on 21 Wall Street analysts who have issued ratings for Affirm in the last 12 months, the stock has a consensus rating of "Hold." Out of the 21 analysts, 5 have given a sell rating, 9 have given a hold rating, and 7 have given a buy rating for AFRM.

Consensus Price Target

$35.53
-13.68% Downside
According to the 21 analysts' twelve-month price targets for Affirm, the average price target is $35.53. The highest price target for AFRM is $65.00, while the lowest price target for AFRM is $12.00. The average price target represents a forecasted downside of -13.68% from the current price of $41.16.
Get the Latest News and Ratings for AFRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Affirm and its competitors.

Sign Up

AFRM Analyst Ratings Over Time

TypeCurrent Forecast
10/1/23 to 9/30/24
1 Month Ago
9/1/23 to 8/31/24
3 Months Ago
7/3/23 to 7/2/24
1 Year Ago
10/1/22 to 10/1/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
4 Buy rating(s)
Hold
9 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
Sell
5 Sell rating(s)
5 Sell rating(s)
5 Sell rating(s)
4 Sell rating(s)
Consensus Price Target$35.53$34.32$32.66$16.22
Forecasted Upside-13.68% Downside-22.01% Downside11.15% Upside-23.73% Downside
Consensus Rating
Hold
Hold
Hold
Hold

AFRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AFRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Affirm Stock vs. The Competition

TypeAffirmBusiness Services CompaniesS&P 500
Consensus Rating Score
2.10
2.66
2.50
Consensus RatingHoldModerate BuyHold
Predicted Upside-13.68% Downside303.06% Upside6.16% Upside
News Sentiment Rating
Positive News

See Recent AFRM News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/23/2024Barclays
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$50.00 ➝ $54.00+20.89%
9/20/2024Susquehanna
2 of 5 stars
J. Friedman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoveragePositive$52.00+15.61%
9/6/2024Needham & Company LLC
2 of 5 stars
 Reiterated RatingHold
8/29/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderperform ➝ Underperform$20.00 ➝ $25.00-40.66%
8/29/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$43.00 ➝ $46.00+17.20%
8/29/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$36.00 ➝ $42.00+33.00%
8/27/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$65.00 ➝ $65.00+103.89%
8/20/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$43.00 ➝ $45.00+44.00%
6/28/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Scharf
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
6/24/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$42.00+40.61%
6/7/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
V. Caintic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral
5/10/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform ➝ Market Perform$48.00 ➝ $46.00+38.68%
2/9/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$6.00 ➝ $16.00-62.47%
2/9/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$24.00 ➝ $35.00-28.89%
12/18/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeEqual Weight ➝ Underweight$15.00 ➝ $20.00-54.51%
12/15/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$33.00 ➝ $55.00+26.38%
11/28/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Hold$9.50 ➝ $30.00+2.15%
11/22/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$19.50 ➝ $21.50-16.76%
11/9/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$11.00 ➝ $12.00-51.77%
11/9/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$17.00 ➝ $20.00-22.99%
10/25/2023Compass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Sell$13.00-33.54%
2/9/2023DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$24.00 ➝ $20.00+45.77%
2/9/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$21.00 ➝ $16.00-0.12%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:15 AM ET.


AFRM Forecast - Frequently Asked Questions

According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for Affirm is $35.53, with a high forecast of $65.00 and a low forecast of $12.00.

21 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Affirm in the last year. There are currently 5 sell ratings, 9 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AFRM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFRM, but not buy additional shares or sell existing shares.

According to analysts, Affirm's stock has a predicted downside of -13.68% based on their 12-month stock forecasts.

Over the previous 90 days, Affirm's stock had 1 upgrade by analysts.

Affirm has been rated by research analysts at Bank of America, Barclays, JPMorgan Chase & Co., Mizuho, Needham & Company LLC, Royal Bank of Canada, Susquehanna, and Wedbush in the past 90 days.

Analysts like Affirm less than other "business services" companies. The consensus rating for Affirm is Hold while the average consensus rating for "business services" companies is Moderate Buy. Learn more on how AFRM compares to other companies.


This page (NASDAQ:AFRM) was last updated on 9/30/2024 by MarketBeat.com Staff
From Our Partners